BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 29353703)

  • 1. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene.
    Azevedo C; Chumarina M; Serafimova E; Goldwurm S; Collin A; Roybon L; Savchenko E; Pomeshchik Y
    Stem Cell Res; 2020 Mar; 43():101694. PubMed ID: 31954327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene.
    Marote A; Pomeshchik Y; Collin A; Goldwurm S; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Apr; 28():44-47. PubMed ID: 29414418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypical Differences in Neuronal Cultures Derived via Reprogramming the Fibroblasts from Patients Carrying Mutations in Parkinsonian Genes LRRK2 and PARK2.
    Konovalova EV; Novosadova EV; Grivennikov IA; Illarioshkin SN
    Bull Exp Biol Med; 2015 Oct; 159(6):772-5. PubMed ID: 26519280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene.
    Pavan C; Jin J; Jong S; Strbenac D; Davis RL; Sue CM; Johnston J; Lynch T; Halliday G; Kirik D; Parish CL; Thompson LH; Ovchinnikov DA
    Stem Cell Res; 2023 Dec; 73():103211. PubMed ID: 37890334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
    Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
    Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an induced pluripotent stem cell line (ZZUi020-A) from a patient with Parkinson's disease harboring the intermediate-length GGC repeat expansions in the NOTCH2NLC gene.
    Fan Y; Liu F; Fan LY; Mao CY; Liu H; Zhang C; Yuan YP; Yang J; Wang YL; Liu YT; Shi CH; Xu YM
    Stem Cell Res; 2021 Apr; 52():102257. PubMed ID: 33626493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
    Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
    Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation.
    Russ K; Marote A; Savchenko E; Collin A; Goldwurm S; Pomeshchik Y; Roybon L
    Stem Cell Res; 2018 Mar; 27():61-64. PubMed ID: 29331938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of induced pluripotent stem cell (iPSC) lines of two asymptomatic individuals carrying a heterozygous exon 7 deletion in Parkin (PRKN) and two non-carriers from the same family.
    Castelo Rueda MP; Gilmozzi V; Riekschnitz DA; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I; Zanon A
    Stem Cell Res; 2022 Apr; 60():102692. PubMed ID: 35121197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a PARK2 homozygous knockout induced pluripotent stem cell line (GIBHi002-A-1) with two common isoforms abolished.
    Zhang M; Ibañez DP; Fan W; Liu H; Zhong X; Wang X; Li Y; Md Abdul M; Li W; Li Y; Ward C; Chen S; Wang D; Qin B; Esteban MA; Zhao P; Luo Z
    Stem Cell Res; 2019 Dec; 41():101602. PubMed ID: 31698191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation.
    Ishikawa KI; Okuzumi A; Yoshino H; Hattori N; Akamatsu W
    Stem Cell Res; 2024 Apr; 76():103323. PubMed ID: 38309147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
    Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
    Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an induced pluripotent stem cell line (EURACi005-A) from a Parkinson's disease patient carrying a homozygous exon 3 deletion in the PRKNgene.
    Zanon A; Riekschnitz D; von Troyer M; Volpato C; Picard A; Cantaloni C; Di Segni M; Silipigni R; Pramstaller PP; Hicks AA; Pichler I
    Stem Cell Res; 2019 Dec; 41():101624. PubMed ID: 31715428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
    Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
    Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
    Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
    Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
    Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
    Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
    Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.